Waltermire Robert E. (CIK 1876996) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-07). Recent activity: Buy MDGL (6,825 shares), Buy MDGL (7,288 shares), Sell MDGL (900 shares), Sell MDGL (1,777 shares), Sell MDGL (1,146 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Buy | 6,825 | $600,054 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Buy | 7,288 | $634,712 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 900 | $301,635 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,777 | $598,458 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,146 | $387,451 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 400 | $135,872 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,657 | $564,623 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,043 | $356,539 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,077 | $369,303 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 4,701 | $1.6M |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,412 | $486,801 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Buy | 2,061 | $0 |
| 2025-03-04 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 1,052 | $358,721 |
| 2025-03-04 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 175 | $59,771 |
| 2025-01-27 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 103 | $34,530 |
| 2025-01-17 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | Sell | 442 | $120,847 |
Source: SEC Form 4 filings · as of 2025-03-07